Abundance Wealth Counselors

Position in GSK — GSK plc

CIK 1767080 STATE COLLEGE, PA

Position in GSK

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$3,458,619

+$1,630,120 QoQ

Shares Held

65,979

+99.1% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.46%

of 13F equity value

Holder Rank

#188

of 1,032 holders

Holding Since

Mar 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Abundance Wealth Counselors holds $44,555,696 across 12 Drug Manufacturers - General names. GSK ranks #7 (7.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	30,368	$7,641,803
2	JNJ	Johnson & Johnson	23,066	$5,858,072
3	AMGN	Amgen Inc	14,911	$5,399,571
4	BMY	Bristol Myers Squibb Co	91,814	$5,290,322
5	NVS	Novartis AG	32,213	$5,048,421
6	LLY	ELI LILLY & Co	4,027	$4,830,105
7	GSK	GSK plc This page	65,979	$3,458,619
8	GILD	Gilead Sciences, Inc.	22,139	$2,797,041

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,458,619	65,979	+99.1%	Shares	Sole	2026-07-23
2026-03-31	$1,828,499	33,131	-4.4%	Shares	Sole	2026-04-23
2025-12-31	$1,700,069	34,667	+0.3%	Shares	Sole	2026-01-26
2025-09-30	$1,491,436	34,556	+2.8%	Shares	Sole	2025-10-22
2025-06-30	$1,291,315	33,628	+32.4%	Shares	Sole	2025-07-21
2025-03-31	$984,073	25,402	+20.9%	Shares	Sole	2025-04-21
2024-12-31	$710,592	21,011	-6.3%	Shares	Sole	2025-01-24
2024-09-30	$916,325	22,415	+3.4%	Shares	Sole	2024-10-17
2024-06-30	$834,834	21,684	+9.4%	Shares	Sole	2024-07-17
2024-03-31	$849,511	19,816	+7.3%	Shares	Sole	2024-04-19
2023-12-31	$684,609	18,473	+11.8%	Shares	Sole	2024-01-17
2023-09-30	$598,705	16,516	+8.4%	Shares	Sole	2023-10-30
2023-06-30	$543,260	15,243	-0.1%	Shares	Sole	2023-07-19
2023-03-31	$542,737	15,254	+15154.0%	Shares	Sole	2023-05-02
2021-03-31	$3,500	100	—	Shares	Sole	2021-05-06
No filing history on record for this holder in this stock.